| __timestamp | Jazz Pharmaceuticals plc | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 1172875000 | 580415000 |
| Thursday, January 1, 2015 | 1324803000 | 1032336000 |
| Friday, January 1, 2016 | 1487973000 | 1702177000 |
| Sunday, January 1, 2017 | 1618693000 | 2488652000 |
| Monday, January 1, 2018 | 1890922000 | 3047597000 |
| Tuesday, January 1, 2019 | 2161761000 | 4162821000 |
| Wednesday, January 1, 2020 | 2363567000 | 6205683000 |
| Friday, January 1, 2021 | 3094238000 | 7574400000 |
| Saturday, January 1, 2022 | 3659374000 | 8930700000 |
| Sunday, January 1, 2023 | 3834204000 | 9869200000 |
| Monday, January 1, 2024 | 11020100000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, Vertex Pharmaceuticals Incorporated and Jazz Pharmaceuticals plc have been pivotal players. Over the past decade, Vertex has consistently outpaced Jazz in revenue growth. Starting in 2014, Vertex's revenue was just over half a billion dollars, but by 2023, it surged to nearly $9.9 billion, marking an impressive growth of over 1,600%. In contrast, Jazz Pharmaceuticals saw its revenue grow from approximately $1.2 billion in 2014 to $3.8 billion in 2023, a more modest increase of around 220%.
This data highlights Vertex's strategic advancements and market positioning, particularly in the biotech sector, where innovation drives success. As both companies continue to innovate, stakeholders and investors will be keenly watching their next moves. The data underscores the dynamic nature of the pharmaceutical industry and the importance of strategic growth and innovation.
Eli Lilly and Company and Jazz Pharmaceuticals plc: A Comprehensive Revenue Analysis
AbbVie Inc. and Vertex Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Revenue Showdown: Sanofi vs Vertex Pharmaceuticals Incorporated
Breaking Down Revenue Trends: Vertex Pharmaceuticals Incorporated vs Grifols, S.A.
Gross Profit Analysis: Comparing Vertex Pharmaceuticals Incorporated and Jazz Pharmaceuticals plc
Vertex Pharmaceuticals Incorporated vs Jazz Pharmaceuticals plc: Strategic Focus on R&D Spending
Breaking Down Revenue Trends: Vertex Pharmaceuticals Incorporated vs Merus N.V.
Vertex Pharmaceuticals Incorporated or Mesoblast Limited: Who Leads in Yearly Revenue?
Revenue Insights: Biogen Inc. and Jazz Pharmaceuticals plc Performance Compared
Bio-Techne Corporation vs Jazz Pharmaceuticals plc: Examining Key Revenue Metrics
Annual Revenue Comparison: Jazz Pharmaceuticals plc vs Halozyme Therapeutics, Inc.
Jazz Pharmaceuticals plc or Veracyte, Inc.: Who Leads in Yearly Revenue?